Edition speaker: 2025
Łukasz Balwicki, MD, PhD, public health specialist, university professor at the Medical University of Gdańsk, head of the Department of Public Health and Social Medicine at the Medical University of Gdańsk. He has served as the national consultant in the field of public health since 2024. Prof. Balwicki is the head of the Department of Public Health and Social Medicine at the Medical University of Gdańsk; Faculty of Health Sciences with the Nursing Department and the Institute of Maritime and Tropical Medicine; Department of Social Medicine. Additionally, he gives lectures on public health at medical faculties, and he is an academic tutor. He also is the head of the University Smoking Cessation Clinic. Prof. Balwicki cooperates as an expert with WHO and the European Observatory on Health Systems and Policies and the National Institute of Public Health – National Institute of Hygiene. He is an author of many scientific publications in the field of tobacco control, including epidemiological aspects of using e-cigarettes among adolescents and the anti-tobacco law. Additionally, he authored practical guides in the field of help for people with tobacco dependency He coordinated many programmes and anti-tobacco campaigns implemented in cooperation with employers, local governments, and institutions of governmental administration. He is the author and leader of anti-tobacco policy programmes financed with Bloomberg Initiative grants conducted in coordination with the WHO and Campaign for Tobacco-Free Kids. top
Małgorzata Bała, MD, PhD works at the Jagiellonian University Medical College in Cracow. She has worked on various aspects of evidence-based healthcare since the beginning of her professional career. She is the co-author of several chapters in the handbook "The principles of EBM – evidence-based medicine for doctors and students of medicine students" (2008) and published many articles on systematic reviews. top
Edition speaker: 2023
Doctor of health sciences with a master’s degree in public health and economics. She is an author of numerous publications on cost effectiveness analysis, integrated care and quality of life. She has many years of teaching experience and she is the author of a unique model for educating students of Public Health in the field of pharmacoeconomics. Ewa Bandurska is the head of the Public Health – management in the health system faculty (first-cycle studies). Moreover, she is a member of the Polish Pharmacoeconomics Society (currently a member of the audit committee), the Polish Society for Health Programs, the Polish Society of Social Medicine and Public Health. She also holds the position of the supervisor of the Management and Economics in Health Care scientific club at the Medical University of Gdańsk and co-supervisor of the ISPOR Student Chapter Poland – a nationwide scientific club for pharmacoeconomics students. Furthermore, Ewa Bandurska cooperates with, among others, the National Institute of Public Health – National Institute of Hygiene, the Medicover Foundation, the World Bank and other entities. top
Edition speaker: 2025
WHO Representative to Poland and Special Envoy for Ukraine Emergency Response in refugee-hosting countries in Europe.
Dr Nino Berdzuli is a physician and public health specialist with more than 18 years of wide-ranging experience in public health and health sector reforms developed through a variety of roles in the international public health consulting companies, high level government position and the World Health Organization. She is a trained Obstetrician/Gynecologist. Prior to her position as Representative of the WHO to Poland and Special Envoy for Ukraine Emergency Response, Dr Berdzuli served as a Director of the Country Health Programs in Copenhagen, leading and managing WHO Regional Office for Europe largest division of Health Programs, providing strategic leadership for communicable and non-communicable diseases, fostering innovations, partnerships and enriching the evidence base for policy design and interventions, and working with countries to strengthen governance and capacities for implementation. From 2015 to 2018, Dr Berdzuli held the position of Deputy Minister of Labor, Health and Social Affairs in Georgia, where she led development and implementation of government strategies for strengthening and implementing Universal Health Care program, e-health strategy, e-prescription system, hospital sector re-organization, and steering legislative changes, including innovative tobacco legislation. In recognition of the work, the Ministry of Labor, Health, and Social Affairs of Georgia awarded Dr Berdzuli with the medal for outstanding contribution to the Ministry`s work. Prior to holding a senior government position, Dr Berdzuli worked in international development in Washington, DC, managing USA-government funded programs and providing technical guidance and oversight to health programs in Eastern Europe, Middle East, South-East Asia and Africa. Dr Berdzuli holds Doctor of Philosophy (PhD) from the Institute of Clinical Medicine at University of Oslo (Norway), Master of Public Health from Rollins School of Public Health at Emory University (USA), and Medical Doctor degree with specialty in Obstetrics & Gynecology from Tbilisi State Medical University (Georgia). top
Edition speaker: 2021
Professor of Pharmacy and Pharmacoepidemiology, University of Strathclyde and Chief Pharmacist, Public Health Scotland. Marion’s joint post is positioned to drive forward an evidence base to better inform the safe and effective use of medicines in routine clinical care. The clinical focus of her research is infection, cardiovascular and cancer including large dataset evaluation to understand evolving patterns of medicines use in routine clinical practice and the development and impact of tailored clinical decision support tools/ health interventions. Marion has lead the provisioning and curation of the Scottish Prescribing Information System (PIS) which captures all individual level community prescribing and dispensing events for the population of Scotland (5.6million) and most recently the national collection and curation of hospital individual level data to support COVID-19 efforts to understand the use and outcome of novel COVID treatments being used in clinical care outwith the clinical trial setting. Current strategic leadership roles include; Associate Director, Health Data Research (HDR) UK Scotland; Immediate past Chair, European Drug Utilisation Research Group (EuroDURG); lead for NHS Scotland Cancer Medicines Outcome Program. Marion is a: Fellow of the Royal Pharmaceutical Society, UK ; a Fellow of the Faculty of Public Health, Royal Colleges of Physicians, UK, and; a fellow of the Royal College of Physicians, Edinburgh. top
Edition speaker: 2024
Preventionist, epidemiologist, economist, public and environmental health specialist. Supreme Medical Council expert in research and analysis. Director of the Strategy and Analysis Centre of the Regional Chamber of Physicians in Warsaw and of the SGH-WUM EMBA programme in health care. Masovian voivodeship consultant in the field of Environmental Health. Academic teacher at the Department of Environmental Hazard Prevention, Allergology and Immunology of the Medical University of Warsaw and the Department of Managerial Accounting at the Warsaw School of Economics. Member of the State Examination Committee of the Medical Examination Centre. Coordinator for the development of forms of postgraduate education at the Centre for Postgraduate Education of the Medical University of Warsaw. top
Stefan Bogusławski has over 30 years of experience in market research and healthcare market consulting. He has managed Sequence and PEX PharmaSequence for over 10 years. Before that, between 1991 and 2007, he was a manager of the Polish and Central European branch of IMS Health and was in charge of Azyx – a research company. top
Edition speaker: 2017
André is responsible for regulatory innovation at Lygature, an independent Dutch foundation fostering public-private partnerships in the development of medicines and medical technology. He is leading the Escher project. Currently André is coordinator of the IMI project ADAPT SMART. He has built up his regulatory experience, both with an European regulatory agency (as Head of Clinical Assessment and as Chief Executive Officer at the Dutch Medicines Evaluation Board) and with major pharmaceutical companies (senior management positions with MSD, Schering Plough, Organon). top
Edition speaker: 2025
Michał Byliniak has been associated with the pharmaceutical market for over 15 years, acquiring extensive managerial experience in the field of distribution, reimbursement, clinical trials and registration of medicinal products. Michał Byliniak was a long-term president of the Regional Pharmaceutical Council in Warsaw, as well as the president of the Pharmaceutical Group of the European Union. Director General of the Employer’s Union of Innovative Pharmaceutical Companies INFARMA since 2022. He has experience in working in the Polish health care system, in various organisations, such as pharmacies, domestic wholesalers, pharmaceutical companies and consulting companies. He is the author of numerous studies related to the pharmaceutical sector. top
English (UK) 
Polski